INS and Hyperinsulinemia: Type 2 (T2) DM accounts for the majority of this increase and is characterized by hyperglycemia resulting from insufficient endogenous insulin secretion due to beta cell dysfunction or hyperinsulinemia and impaired tissue response to insulin [1].